ALEXANDER HU D.O. NPI 1306145859

NPI Details

Alexander Hu, D.O. is an internal medicine in Flagstaff, AZ with 15 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Alexander Hu, D.O. NPI is 1306145859. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

399 S MALPAIS LN
FLAGSTAFF, AZ
ZIP 86001-218
Phone: (480) 443-8400

The NPI 1306145859 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg (HCPCS:Q5103)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab-axxq, biosimilar, (avsola), 10 mg (HCPCS:Q5121)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Analysis for antibody to coccidioides (bacteria) (HCPCS:86635)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Hepatitis c antibody measurement (HCPCS:86803)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Uric acid level, blood (HCPCS:84550)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Vitamin d-3 level (HCPCS:82306)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Rheumatoid factor level (HCPCS:86431)
• Screening test for autoimmune disorder (HCPCS:86038)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Urinalysis, manual test (HCPCS:81002)
• Injection into tendon or ligament (HCPCS:20550)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)

The enumeration date for this NPI number is 3/23/2011 and was last updated on 8/18/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.